FIELD: medicine, pharmaceutics.
SUBSTANCE: described is a novel crystalline salt of sitagliptin - sitagliptin malate and containing it pharmaceutical composition; the described salt is dipeptidylpeptidase-IV inhibitor and can be applied in medicine in treatment of type 2 diabetes mellitus.
EFFECT: invention can be applied in medicine in treatment of type 2 diabetes mellitus.
2 cl, 17 ex, 29 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USEFUL PHARMACEUTICAL SALTS OF 7-[(3R,4R)-3-HYDROXY-4-HYDROXYMETHYL-PYRROLIDINE-1-YLMETHYL]-3,5-DIHYDRO-PYRROLO[3,2-D] PYRIMIDINE-4-ONE | 2010 |
|
RU2489435C2 |
| DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
| N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(2-METHYLPROPYLOXY)PHENYLMETHYL) CARBAMIDE SALTS AND PREPARATION OF SAID SALTS | 2005 |
|
RU2387643C2 |
| POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF | 2014 |
|
RU2658009C2 |
| CRYSTALLINE FORMS OF 6-(1H-IMIDAZOL-1-YL)-2-PHENYLQUINAZOLINE AND ITS SALTS | 2010 |
|
RU2557547C2 |
| METHODS OF PRODUCTION ISOQUINOLINONES AND SOLID FORMS ISOQUINOLINONES | 2012 |
|
RU2626883C2 |
| CRYSTAL SALTS OF B-RAF-KINASE INHIBITOR | 2018 |
|
RU2798091C2 |
| POLYMORPHOUS FORMS OF SODIUM BENZOATE AND THEIR USE | 2017 |
|
RU2782627C2 |
| ROMIDEPSIN SOLID FORMS AND USE THEREOF | 2011 |
|
RU2607634C2 |
| POLYMORPHOUS AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | 2015 |
|
RU2770091C2 |
